// App-Quantinova.ai

P200 : Characterisation of remission in patients with rheumatoid arthritis treated with upadacitinib or comparators

Researchers

Presenter

  • Stephen Hall

Principal Investigators

  • Tsutomu Takeuchi

  • Glen Thomson

  • Paul Emery

  • Bernard Combe

  • Andrea Everding

  • Karel Pavelka

  • Yanna Song

  • Tim Shaw

  • Alan Friedman

  • In-Ho Song

  • Eduardo Mysler

Medical Centers

  • Cabrini Health and Emeritus Research, Monash University, Malvern, AUSTRALIA

  • School of Medicine, Keio University, Tokyo, Japan

  • CIADS, Research, Winnipeg, MB, CANADA

  • Leeds Inst of Rheumatic & Musculoskeletal Medicine, Leeds NIHR BRC, Leeds, UNITED KINGDOM

  • CHU Montpellier, University Montpellier, Montpellier, FRANCE

  • HRF Hamburger Rheuma Forschungszentrum, Hamburg, Germany

  • Department of Rheumatology, Charles University, Prague, AUSTRALIA

  • AbbVie Inc, Waukegan Road, North Chicago, IL

  • OMI, Organización Medica de Investigación, Buenos Aires, ARGENTINA

Locations

  • Australia

  • Japan

  • Canada

  • United Kingdom

  • France

  • Germany

  • United States

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • ABT-494

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved